Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ductal Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06903468
What this trial is testing

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who this might be right for
Ductal Carcinoma in SituBreast Cancer
University of Florida 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05591547
What this trial is testing

Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen

Who this might be right for
Breast Cancer
Sanford Health 91
Not applicableStudy completedNCT04206891
What this trial is testing

CDH1 Germline Mutations in Lobular Breast Cancer

Who this might be right for
Lobular Breast CarcinomaCDH1 Gene Inactivation
European Institute of Oncology 421
Not applicableNot Yet RecruitingNCT06860217
What this trial is testing

Robotic Nipple Sparing Mastectomy with Immediate Reconstruction

Who this might be right for
Breast CancerDCISBRCA Mutation
European Institute of Oncology 24
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Testing effectiveness (Phase 2)Looking for participantsNCT07483307
What this trial is testing

The Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 176
Not applicableWithdrawnNCT05032079
What this trial is testing

Subzero and Scorpion Trial

Who this might be right for
Ductal Carcinoma in Situ
Larkin Community Hospital
Not applicableUnknownNCT01034891
What this trial is testing

Women At Risk: The High Risk Breast Cancer Program

Who this might be right for
Breast Cancer
New York Presbyterian Hospital 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Early research (Phase 1)Study completedNCT00245024
What this trial is testing

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 30
Early research (Phase 1)WithdrawnNCT00937417
What this trial is testing

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
SWOG Cancer Research Network
Not applicableStudy completedNCT06982313
What this trial is testing

Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms

Who this might be right for
Breast Cancer Invasive
Ente Ospedaliero Ospedali Galliera 1,545
Testing effectiveness (Phase 2)Study completedNCT03703492
What this trial is testing

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ - Category
University of Wisconsin, Madison 12
Testing effectiveness (Phase 2)Study completedNCT03002766
What this trial is testing

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Carcinoma Breast
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 224
Not applicableStudy completedNCT00890994
What this trial is testing

Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Breast Cancer
Mayo Clinic 200
Not applicableStudy completedNCT00081003
What this trial is testing

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT01266642
What this trial is testing

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituInvasive Breast CarcinomaStage I Breast Cancer AJCC v6+5 more
M.D. Anderson Cancer Center 301
Large-scale testing (Phase 3)Study completedNCT00769379
What this trial is testing

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 2,014
Not applicableStudy completedNCT04225585
What this trial is testing

Well-Being After Breast Cancer Surgery

Who this might be right for
Coping Skills Training for Persistent Post-Surgical PainGeneral Health Education
Duke University 316
Early research (Phase 1)Looking for participantsNCT07213791
What this trial is testing

LY4337713 in Participants With FAP-Positive Solid Tumors

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsPancreatic Intraductal Neoplasms+4 more
Eli Lilly and Company 241
Next Page